Intra-Cellular Stock Future Price Prediction


USD 55.17  1.91  3.35%   

Intra-Cellular Ther stock price prediction is an act of determining the future value of Intra-Cellular Ther shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Intra-Cellular Ther's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Intra-Cellular Ther and does not consider all of the tangible or intangible factors available from Intra-Cellular Ther's fundamental data. We analyze noise-free headlines and recent hype associated with Intra-Cellular Ther, which may create opportunities for some arbitrage if properly timed.
Please see Intra-Cellular Ther Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Intra-Cellular Ther based on different types of headlines from major news networks to social media. The Intra-Cellular stock price prediction module provides an analysis of price elasticity to changes in media outlook on Intra-Cellular Ther over a specific investment horizon.
EPS Estimate Current Year
EPS Estimate Next Year
Wall Street Target Price
EPS Estimate Current Quarter
Quarterly Revenue Growth YOY
Using Intra-Cellular Ther hype-based prediction, you can estimate the value of Intra-Cellular Ther from the perspective of Intra-Cellular Ther response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Intra-Cellular Ther using Intra-Cellular Ther's options and short interest. It helps to benchmark the overall future attitude of investors towards Intra-Cellular using crowd psychology based on the activity and movement of Intra-Cellular Ther's stock price.
Intra-Cellular Ther Accrued Expenses Turnover is most likely to increase slightly in the upcoming years. The last year's value of Accrued Expenses Turnover was reported at 4.01. The current Cash and Equivalents Turnover is estimated to increase to 1.18, while Return on Investment is projected to decrease to (57.36) .

Intra-Cellular Ther Implied Volatility

Intra-Cellular Ther's implied volatility exposes the market's sentiment of Intra-Cellular Ther stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Intra-Cellular Ther's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Intra-Cellular Ther stock will not fluctuate a lot when Intra-Cellular Ther's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Intra-Cellular Ther. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Intra-Cellular Ther to buy its stock at a price that has no basis in reality. In that case, they are not buying Intra-Cellular because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Intra-Cellular Ther after-hype prediction price

  $ 55.11  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Intra-Cellular Ther's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Intra-Cellular Ther in the context of predictive analytics.
LowReal ValueHigh
LowNext ValueHigh
7 Analysts
LowTarget PriceHigh
Estimates (5)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Intra-Cellular Ther. Your research has to be compared to or analyzed against Intra-Cellular Ther's peers to derive any actionable benefits. When done correctly, Intra-Cellular Ther's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Intra-Cellular Ther.

Intra-Cellular Ther After-Hype Price Prediction Density Analysis

As far as predicting the price of Intra-Cellular Ther at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Intra-Cellular Ther or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Intra-Cellular Ther, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Intra-Cellular Ther Estimiated After-Hype Price Volatility

In the context of predicting Intra-Cellular Ther's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Intra-Cellular Ther's historical news coverage. Intra-Cellular Ther's after-hype downside and upside margins for the prediction period are 50.70 and 59.52, respectively. We have considered Intra-Cellular Ther's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 55.17
After-hype Price
Intra-Cellular Ther is very steady asset. Analysis and calculation of next after-hype price of Intra-Cellular Ther is based on 3 months time horizon.

Intra-Cellular Ther Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Intra-Cellular Ther is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Intra-Cellular Ther backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Intra-Cellular Ther, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.12  4.41   0.06   0.01  9 Events / Month9 Events / MonthIn about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Intra-Cellular Ther Hype Timeline

Intra-Cellular Ther is currently traded for 55.17. The entity has historical hype elasticity of -0.06 and average elasticity to hype of competition of 0.01. Intra-Cellular is forecasted to decline in value after the next headline with price expected to drop to 55.11. The average volatility ofmedia hypeimpact on the company stock price is over 100%. The price decrease on the next newsis expected to be -0.11% whereas the daily expected return is currently at -0.12%. The volatility of related hype on Intra-Cellular Ther is about 6041.1% with expected price after next announcement by competition of 55.18. About 87.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.2. Intra-Cellular Ther had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecastedpress releasewill be in about 9 days.
Please see Intra-Cellular Ther Basic Forecasting Models to cross-verify your projections.

Intra-Cellular Ther Related Hype Analysis

Having access to credible news sources related to Intra-Cellular Ther's direct competition is more important than ever and may enhance your ability to predict Intra-Cellular Ther's future price movements. Getting to know how Intra-Cellular Ther rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Intra-Cellular Ther may potentially react to the hype associated with one of its peers.
At Risk
IBMInternational Business Machines 0.70 8 per month 1.41  0.19  2.47 (2.47)  11.05 
PGProcter Gamble(0.36) 11 per month 0.00  0.07  2.54 (2.30)  8.89 
KOCoca-Cola 0.09 7 per month 1.75  0.17  2.14 (2.01)  10.05 
JNJJohnson Johnson 1.84 10 per month 1.06  0.18  2.23 (1.86)  5.89 
BLUBellus Health(0.27) 5 per month 4.69  0.17  8.52 (7.43)  27.61 
CSCOCisco Systems(0.32) 7 per month 0.00 (0.08)  2.73 (3.26)  17.06 
MSFTMicrosoft Corp 1.73 9 per month 0.00 (0.0357)  2.97 (4.24)  9.36 
INTCIntel Corp 0.31 8 per month 0.00 (0.14)  3.14 (3.64)  10.50 
DDDupont Denemours(2.11) 10 per month 0.00 (0.16)  3.00 (3.87)  9.53 
PFEPfizer Inc(0.88) 11 per month 1.94  0.11  3.17 (3.16)  8.45 

Intra-Cellular Ther Additional Predictive Modules

Most predictive techniques to examine Intra-Cellular price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Intra-Cellular using various technical indicators. When you analyze Intra-Cellular charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Intra-Cellular Ther Predictive Indicators

The successful prediction of Intra-Cellular Ther stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Intra-Cellular Ther, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Intra-Cellular Ther based on analysis of Intra-Cellular Ther hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Intra-Cellular Ther's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Intra-Cellular Ther's related companies.
 2018 2020 2021 2022 (projected)
Accrued Expenses Turnover0.01031.874.014.33
Accounts Payable Turnover0.0056683.5211.8112.74

Story Coverage note for Intra-Cellular Ther

The number of cover stories for Intra-Cellular Ther depends on current market conditions and Intra-Cellular Ther's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Intra-Cellular Ther is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Intra-Cellular Ther's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Intra-Cellular Ther Short Properties

Intra-Cellular Ther's future price predictability will typically decrease when Intra-Cellular Ther's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Intra-Cellular Ther often depends not only on the future outlook of the potential Intra-Cellular Ther's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intra-Cellular Ther's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out3.54%
Short Percent Of Float4.07%
Float Shares86.54M
Shares Short Prior Month3.85M
Average Daily Volume Last 10 Day942.01k
Average Daily Volume In Three Month900.38k
Date Short Interest29th of April 2022
Please see Intra-Cellular Ther Basic Forecasting Models to cross-verify your projections. Note that the Intra-Cellular Ther information on this page should be used as a complementary analysis to other Intra-Cellular Ther's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Intra-Cellular Stock analysis

When running Intra-Cellular Ther price analysis, check to measure Intra-Cellular Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intra-Cellular Ther is operating at the current time. Most of Intra-Cellular Ther's value examination focuses on studying past and present price action to predict the probability of Intra-Cellular Ther's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Intra-Cellular Ther's price. Additionally, you may evaluate how the addition of Intra-Cellular Ther to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bond Directory
Find actively traded corporate debentures issued by US companies
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Intra-Cellular Ther's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intra-Cellular Ther. If investors know Intra-Cellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intra-Cellular Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
5.2 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Intra-Cellular Ther is measured differently than its book value, which is the value of Intra-Cellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intra-Cellular Ther's value that differs from its market value or its book value, called intrinsic value, which is Intra-Cellular Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intra-Cellular Ther's market value can be influenced by many factors that don't directly affect Intra-Cellular Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intra-Cellular Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine Intra-Cellular Ther value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intra-Cellular Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.